caprylates has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 5 studies
| Studies (caprylates) | Trials (caprylates) | Recent Studies (post-2010) (caprylates) | Studies (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) | Trials (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) | Recent Studies (post-2010) (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) |
|---|---|---|---|---|---|
| 5,061 | 100 | 2,339 | 2,577 | 27 | 327 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, DS; Furness, P; Goldstein, R; Lee, W; Main, AJ | 1 |
| Bhagwat, SS; Boswell, C; Cohen, DS; Furness, P; Goldstein, R; Gude, C; Lee, W; Louzan, M; Main, AJ | 1 |
| Bhagwat, SS; Boswell, C; Cohen, DS; Contardo, N; Dotson, R; Furness, P; Gude, C; Lee, W; Mathis, J; Zoganas, H | 1 |
| Chapleau, MW; Li, Z; Su, X | 1 |
| Bhagwat, SS; Cohen, DS; Dotson, R; Furness, P; Gude, C; Lee, W; Mathis, J | 1 |
5 other study(ies) available for caprylates and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 2. Synthesis and biological activity of 8-(benzenesulfonamido)-7-(3-pyridinyl)octaonic acid and related compounds.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Caprylates; Humans; Male; Muscle, Smooth, Vascular; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridines; Rabbits; Receptors, Thromboxane; Sulfonamides; Thromboxane-A Synthase; Vasoconstriction; Vasoconstrictor Agents | 1992 |
Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 3. Pyridinylalkyl-substituted 8-[(arylsulfonyl)amino]octanoic acids.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Caprylates; Dogs; Humans; Muscle, Smooth; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridines; Receptors, Thromboxane; Structure-Activity Relationship; Thromboxane-A Synthase; Vasoconstrictor Agents | 1992 |
Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 4. 8-[[(4-Chlorophenyl)sulfonyl]amino]-4-(3-(3-pyridinyl) propyl)octanoic acid and analogs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bronchoconstriction; Caprylates; Dogs; Guinea Pigs; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridines; Receptors, Thromboxane; Structure-Activity Relationship; Sulfonamides; Thromboxane-A Synthase; Vasoconstrictor Agents | 1992 |
Role of cyclooxygenase metabolites in mediating platelet-induced baroreceptor dysfunction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Platelets; Caprylates; Carotid Arteries; Female; Indomethacin; Male; Platelet Activation; Pressoreceptors; Pressure; Prostaglandin Endoperoxides, Synthetic; Prostaglandin-Endoperoxide Synthases; Rabbits; Sulfonamides; Thrombin; Thromboxane A2; Thromboxane-A Synthase; Vasoconstriction | 1995 |
Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 5. Synthesis and evaluation of enantiomers of 8-[[(4-chlorophenyl)sulfonyl]amino]-4-(3-pyridinylalkyl)octanoic acid.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Caprylates; Guinea Pigs; Humans; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Pyridines; Receptors, Thromboxane; Stereoisomerism; Structure-Activity Relationship; Sulfonamides; Thromboxane-A Synthase; Vasoconstrictor Agents | 1993 |